Surveilling the threat of ovarian cancer
Currently, ovarian cancer is the fifth most frequent cause of cancer-related deaths for women in Western countries, largely due to its often illusive symptoms and lack of adequate screening methods.
“Participating in research on ovarian cancer has been a rewarding experience. I have learned what it means to be a researcher, what we do in the lab is for the greater good of society,” says Rebeca.
Alongside Dr. Patricia Tonin from McGill University’s Department of Human Genetics, she is investigating genetic abnormalities of ovarian cancer specimens. The objective is to improve upon screening and surveillance methods by investigating the role of genetic events and related cancer susceptible genes that occur in ovarian cancer.
When asked why she ultimately chose Mitacs Globalink, Rebeca explains, “Globalink presents all the best opportunities. Not only am I participating in a field of research of my choosing, but I am also taking part in workshops that teach industry-ready skills, all the while working in top-notch research facilities.”
Rebeca explains her dreams for the future, “I want to keep doing what I love to do most, research. I will be applying to grad school, and after my experience here, I intend on doing so in Canada.”
Mitacs would like to thank the following government and international partners, in addition to our full and associate university partners, for their support of Globalink in 2013: Western Economic Diversification Canada, the Government of Alberta, the Government of British Columbia, Le Fonds de recherche du Québec – Nature et technologies, le Coordenação de Aperfeiçoamento de Pessoal de Nível Superior of Brazil, the China Scholarship Council, the Monterrey Institute of Technology and Higher Education and the National Autonomous University of Mexico